SCHEMBL14225271

SCHEMBL14225271

c1cnc2c(-c3cc(-c4cccc5cccnc45)nc(-c4cc(-c5nc(-c6cccc7cccnc67)cc(-c6cccc7cccnc67)n5)cc(-c5nc6ccccc6o5)c4)n3)cccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.49
KDM4E B2RXH2 10/20 0.49
NPC1 O15118 10/20 0.49
TP53 P04637 9/20 0.49
HSD17B10 Q99714 9/20 0.49
HPGD P15428 9/20 0.49
RAB9A P51151 9/20 0.49
SMN1; SMN2 Q16637 8/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
MAPT P10636 4/20 0.43
PKM P14618 3/20 0.43
HCRTR1 O43613 2/20 0.43
TOP2A P11388 1/20 0.42
USP2 O75604 1/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14225262 0.95 TP53 (0.47) ALDH1A1KDM4ENPC1TP53HSD17B10
SCHEMBL14225172 0.93 NPC1 (0.49) ALDH1A1KDM4ENPC1TP53HSD17B10
SCHEMBL14225338 0.89 TP53 (0.49) ALDH1A1KDM4ENPC1TP53HSD17B10
SCHEMBL14225274 0.86 KDM4E (0.53) ALDH1A1KDM4ENPC1TP53HSD17B10
SCHEMBL23079997 0.85 NPC1 (0.48) ALDH1A1KDM4ENPC1TP53HSD17B10
SCHEMBL23079940 0.84 NPC1 (0.52) ALDH1A1KDM4ENPC1TP53HSD17B10
SCHEMBL23079874 0.84 NPC1 (0.52) ALDH1A1KDM4ENPC1TP53HSD17B10
SCHEMBL23079930 0.84 NPC1 (0.52) ALDH1A1KDM4ENPC1TP53HSD17B10
SCHEMBL23079935 0.84 NPC1 (0.52) ALDH1A1KDM4ENPC1TP53HSD17B10
SCHEMBL14225265 0.84 KDM4E (0.51) ALDH1A1KDM4ENPC1TP53HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9136481-B2 Compound for an organic photoelectric device, organic photoelectric device including the same, and display device including the organic photoelectric device CHEIL INDUSTRIES, INC. (KR) 2015-09-15 US disclosed
US-9136481-B2 Compound for an organic photoelectric device, organic photoelectric device including the same, and display device including the organic photoelectric device CHEIL INDUSTRIES, INC. (KR) 2015-09-15 US disclosed
US-20120313091-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE ORGANIC PHOTOELECTRIC DEVICE CHEIL INDUSTRIES, INC. (KR) 2012-12-13 US disclosed
US-20120313091-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE ORGANIC PHOTOELECTRIC DEVICE CHEIL INDUSTRIES, INC. (KR) 2012-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120313091-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE ORGANIC PHOTOELECTRIC DEVICE PPOX, AOX1, PNPO ALDH1A1 19/4885KDM4E 1643/4885NPC1 4418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.